Jaime Bartushak
2016
In 2016, Jaime Bartushak earned a total compensation of $193.7K as Chief Financial Officer at Citius Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $50,500 |
---|---|
Option Awards | $18,200 |
Salary | $125,000 |
Total | $193,700 |
Bartushak received $125K in salary, accounting for 65% of the total pay in 2016.
Bartushak also received $50.5K in non-equity incentive plan and $18.2K in option awards.
Rankings
In 2016, Jaime Bartushak's compensation ranked 13,447th out of 14,075 executives tracked by ExecPay. In other words, Bartushak earned more than 4.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,447 | 5th |
Manufacturing | 5,250 | 4th |
Chemicals And Allied Products | 1,840 | 3rd |
Drugs | 1,493 | 3rd |
Pharmaceutical Preparations | 1,136 | 3rd |
Bartushak's colleagues
We found two more compensation records of executives who worked with Jaime Bartushak at Citius Pharmaceuticals in 2016.
News
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018